Australia To Address Supply Chain Issues In Medicines Access Review
Policy May Be Extended To Vaccines & Devices
Executive Summary
Stakeholders are being asked to say what they think of plans to future-proof the framework that governs access to medicines and is intended to help bolster the pharmaceutical sector.
You may also be interested in...
Australia Seeks Views On Revised National Medicines Policy
As part of its ongoing review of the National Medicines Policy, Australia’s Department of Health calls for “robust and transparent prioritization of spending on medicines” as well as a collective approach to ensuring speedy and equitable access to affordable medicines for all communities.
Australian Industry Signs Deal To Fund Access To Innovative New Drugs
Hot on the heels of Australia’s plan to overhaul the National Medicines Policy comes a new deal with the pharmaceutical industry to make new drugs available as soon as possible after approval and get patients more closely involved in reimbursement processes.
Australia Launches Review Into Medicines Access & Affordability
Time has taken its toll on Australia’s National Medicines Policy since it was implemented in 2000.